Results 291 to 300 of about 215,802 (313)

Assays for Cyclin-Dependent Kinase Inhibitors

2004
openaire   +2 more sources

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

Lancet, The, 2011
Klemens Budde, Claudia Sommerer, Petra Reinke   +2 more
exaly  

SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study

Lancet, The, 1999
Katherine Samaras, Donald J Chisholm
exaly  

Hereditary angioedema with normal C1-inhibitor activity in women

Lancet, The, 2000
Konrad Bork
exaly  

Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial

Lancet, The, 2017
Marc A Riedl, Avner Reshef, Sladjana Andrejevic   +2 more
exaly  

Cyclin-dependent Kinase Inhibitor 1B

2006
openaire   +1 more source

The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

Nature Reviews Drug Discovery, 2010
exaly  

Inhibitor of Cyclin-Dependent Kinase

2008
openaire   +1 more source

Cyclin-dependent Kinase Inhibitor 2A

2011
openaire   +1 more source